Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00543933 · ClinicalTrials.gov registry record · Early Phase 1
Pilot Study of Inhaled Nitric Oxide to Treat Pulmonary Insufficiency in Congenital Heart Disease
A Early Phase 1 study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 18
- Enrollment target
NCT00543933 is a Early Phase 1 study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 18 participants.
The verdict
NCT00543933, a Early Phase 1 study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
Inhaled nitric oxide in patients with pulmonic valve insufficiency.
Interventions
- DRUG iNO administered
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2007-10 |
| Est. Completion | 2010-06 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00543933
The ClinicalTrials.gov registry entry for NCT00543933 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which iNO administered is the first listed.
NCT00543933 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00543933 about?
NCT00543933 is a clinical study titled "Pilot Study of Inhaled Nitric Oxide to Treat Pulmonary Insufficiency in Congenital Heart Disease". Inhaled nitric oxide in patients with pulmonic valve insufficiency.
What is the current status of trial NCT00543933?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 18 participants. The study started on 2007-10. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00543933?
The interventions under investigation include: iNO administered (DRUG).
Who is sponsoring clinical trial NCT00543933?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.